Impact of sodium–glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria

BACKGROUND: We compared the effects of sodium–glucose cotransporter 2 (SGLT2) inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease (CKD) classified by degree of albuminuria. METHODS: A retrospective review of the clinical records of Japanese participants with...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Akinobu, Miyoshi, Hideaki, Kameda, Hiraku, Yamashita, Kumiko, Kurihara, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954503/
https://www.ncbi.nlm.nih.gov/pubmed/31938043
http://dx.doi.org/10.1186/s13098-020-0516-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954503/
https://www.ncbi.nlm.nih.gov/pubmed/31938043
http://dx.doi.org/10.1186/s13098-020-0516-9

Ejemplares similares